| __timestamp | Bausch Health Companies Inc. | GSK plc |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 8246000000 |
| Thursday, January 1, 2015 | 2682700000 | 9232000000 |
| Friday, January 1, 2016 | 2810000000 | 9366000000 |
| Sunday, January 1, 2017 | 2582000000 | 9672000000 |
| Monday, January 1, 2018 | 2473000000 | 9915000000 |
| Tuesday, January 1, 2019 | 2554000000 | 11402000000 |
| Wednesday, January 1, 2020 | 2367000000 | 11456000000 |
| Friday, January 1, 2021 | 2624000000 | 10975000000 |
| Saturday, January 1, 2022 | 2625000000 | 8372000000 |
| Sunday, January 1, 2023 | 2917000000 | 9385000000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical landscape, understanding spending patterns is crucial. Over the past decade, GSK plc and Bausch Health Companies Inc. have demonstrated distinct approaches to their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, GSK's SG&A expenses consistently outpaced Bausch Health's, averaging nearly four times higher. Notably, GSK's peak spending occurred in 2019, with a 14% increase from 2014, while Bausch Health saw a 44% rise in 2023 compared to its 2014 figures. This divergence highlights GSK's robust investment in administrative functions, contrasting with Bausch Health's more conservative approach. Such insights are pivotal for investors and stakeholders aiming to gauge financial strategies and market positioning. As the industry faces new challenges, these spending patterns may offer a glimpse into future strategic directions.
Breaking Down SG&A Expenses: Novartis AG vs Bausch Health Companies Inc.
Comparing SG&A Expenses: Amgen Inc. vs GSK plc Trends and Insights
GSK plc or Takeda Pharmaceutical Company Limited: Who Manages SG&A Costs Better?
Breaking Down SG&A Expenses: GSK plc vs Biogen Inc.
SG&A Efficiency Analysis: Comparing GSK plc and Summit Therapeutics Inc.
Cost Management Insights: SG&A Expenses for GSK plc and MorphoSys AG
Selling, General, and Administrative Costs: GSK plc vs Dynavax Technologies Corporation
Cost Management Insights: SG&A Expenses for GSK plc and Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: GSK plc vs BioCryst Pharmaceuticals, Inc.
Comparing SG&A Expenses: Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Bausch Health Companies Inc.
Comparing SG&A Expenses: Bausch Health Companies Inc. vs Protagonist Therapeutics, Inc. Trends and Insights